Literature DB >> 14533653

Toxic mold: phantom risk vs science.

Jean A Chapman1, Abba I Terr, Robert L Jacobs, Ernest N Charlesworth, Emil J Bardana.   

Abstract

OBJECTIVE: To review the available literature on the subject of fungi (molds) and their potential impact on health and to segregate information that has scientific validity from information that is yet unproved and controversial. DATA SOURCES: This review represents a synthesis of the available literature in this area with the authors' collective experience with many patients presenting with complaints of mold-related illness. STUDY SELECTION: Pertinent scientific investigation on toxic mold issues and previously published reviews on this and related subjects that met the educational objectives were critically reviewed.
RESULTS: Indoor mold growth is variable, and its discovery in a building does not necessarily mean occupants have been exposed. Human response to fungal antigens may induce IgE or IgG antibodies that connote prior exposure but not necessarily a symptomatic state. Mold-related disease has been discussed in the framework of noncontroversial and controversial disorders.
CONCLUSIONS: When mold-related symptoms occur, they are likely the result of transient irritation, allergy, or infection. Building-related illness due to mycotoxicosis has never been proved in the medical literature. Prompt remediation of water-damaged material and infrastructure repair should be the primary response to fungal contamination in buildings.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14533653     DOI: 10.1016/S1081-1206(10)63522-3

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  8 in total

1.  Guest editorial--novel insights into the pathology of Stachybotrys chartarum.

Authors:  Iwona Yike; Dorr Dearborn
Journal:  Mycopathologia       Date:  2011-04-20       Impact factor: 2.574

Review 2.  The Role of Environmental Controls in Managing Asthma in Lower-Income Urban Communities.

Authors:  Laura Conrad; Matthew S Perzanowski
Journal:  Clin Rev Allergy Immunol       Date:  2019-12       Impact factor: 8.667

Review 3.  Mold and human health: separating the wheat from the chaff.

Authors:  H David Pettigrew; Carlo F Selmi; Suzanne S Teuber; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

4.  The fungal phenomenon.

Authors:  Roger W Fox
Journal:  Curr Allergy Asthma Rep       Date:  2004-11       Impact factor: 4.919

Review 5.  Are Some Fungal Volatile Organic Compounds (VOCs) Mycotoxins?

Authors:  Joan W Bennett; Arati A Inamdar
Journal:  Toxins (Basel)       Date:  2015-09-22       Impact factor: 4.546

6.  Abridged version of the AWMF guideline for the medical clinical diagnostics of indoor mould exposure: S2K Guideline of the German Society of Hygiene, Environmental Medicine and Preventive Medicine (GHUP) in collaboration with the German Association of Allergists (AeDA), the German Society of Dermatology (DDG), the German Society for Allergology and Clinical Immunology (DGAKI), the German Society for Occupational and Environmental Medicine (DGAUM), the German Society for Hospital Hygiene (DGKH), the German Society for Pneumology and Respiratory Medicine (DGP), the German Mycological Society (DMykG), the Society for Pediatric Allergology and Environmental Medicine (GPA), the German Federal Association of Pediatric Pneumology (BAPP), and the Austrian Society for Medical Mycology (ÖGMM).

Authors:  Gerhard A Wiesmüller; Birger Heinzow; Ute Aurbach; Karl-Christian Bergmann; Albrecht Bufe; Walter Buzina; Oliver A Cornely; Steffen Engelhart; Guido Fischer; Thomas Gabrio; Werner Heinz; Caroline E W Herr; Jörg Kleine-Tebbe; Ludger Klimek; Martin Köberle; Herbert Lichtnecker; Thomas Lob-Corzilius; Rolf Merget; Norbert Mülleneisen; Dennis Nowak; Uta Rabe; Monika Raulf; Hans Peter Seidl; Jens-Oliver Steiß; Regine Szewszyk; Peter Thomas; Kerttu Valtanen; Julia Hurraß
Journal:  Allergo J Int       Date:  2017-02-28

7.  Prevalence and risk factors of pre-sick building syndrome: characteristics of indoor environmental and individual factors.

Authors:  Yoshitake Nakayama; Hiroko Nakaoka; Norimichi Suzuki; Kayo Tsumura; Masamichi Hanazato; Emiko Todaka; Chisato Mori
Journal:  Environ Health Prev Med       Date:  2019-12-17       Impact factor: 3.674

8.  Sick building syndrome and associated risk factors among the population of Gondar town, northwest Ethiopia.

Authors:  Haileab Belachew; Yibeltal Assefa; Gebisa Guyasa; Jember Azanaw; Tsegaye Adane; Henok Dagne; Zemichael Gizaw
Journal:  Environ Health Prev Med       Date:  2018-10-27       Impact factor: 3.674

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.